Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.

ABSTRACT: Pandemic (H1N1) 2009 influenza is affecting countries in all five continents, with most cases so far having been reported in North and South America and Europe, and children and young adults being the most susceptible age groups. To date, the clinical course of disease is typically mild, with low hospitalization and mortality rates. Pandemic (H1N1) 2009 is susceptible to oseltamivir and, although few clinical data are yet available, current information suggests that treatment with oseltamivir appears to be beneficial. Only isolated cases of resistance to the drug have been reported to date, in keeping with the low frequency observed in clinical studies involving patients infected with seasonal influenza viruses. Current health authority guidelines recommend the use of oseltamivir in infect

SUBMITTER: Reddy D 

PROVIDER: S-EPMC2835510 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature